Stockscreener 앱 받기
0.7078
1.30%
-0.0093
시간 외 거래:
.69
-0.0178
-2.51%
전일 마감가:
$0.7171
열려 있는:
$0.7
하루 거래량:
1.27M
Relative Volume:
0.40
시가총액:
$40.10M
수익:
-
순이익/손실:
$-50.81M
주가수익비율:
-0.5757
EPS:
-1.2294
순현금흐름:
$-52.80M
1주 성능:
+17.38%
1개월 성능:
+5.82%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.666
$0.7394
1주일 범위
$0.5701
$0.83
52주 변동 폭
$0.50
$3.6999
Cypherpunk Technologies Inc Stock (CYPH) Company Profile
명칭
Cypherpunk Technologies Inc
전화
617 252 4343
주소
47 THORNDIKE STREET, CAMBRIDGE
Compare CYPH vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYPH
Cypherpunk Technologies Inc
|
0.7078 | 40.63M | 0 | -50.81M | -52.80M | -1.2294 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cypherpunk Technologies Inc Stock (CYPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-01-29 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2021-10-04 | 개시 | Mizuho | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2020-06-29 | 개시 | Piper Sandler | Overweight |
| 2020-02-11 | 개시 | Robert W. Baird | Outperform |
| 2019-11-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-09-13 | 재개 | Raymond James | Outperform |
| 2017-03-07 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Cypherpunk Technologies Inc 주식(CYPH)의 최신 뉴스
Top Cypherpunk Technologies (CYPH) Competitors 2026 - MarketBeat
Cypherpunk Technologies (CYPH) Stock Forecast and Price Target 2026 - MarketBeat
Cypherpunk Technologies Inc. - AD HOC NEWS
Cypherpunk Technologies (CYPH) director converts 104,500 RSUs to 152,500 share stake - Stock Titan
Cypherpunk (CYPH) director converts 168,750 vested RSUs into common stock - Stock Titan
Director at Cypherpunk (CYPH) receives 168,750 shares from RSUs - Stock Titan
Director William Li of Cypherpunk (CYPH) receives 168,750 shares from RSU settlements - Stock Titan
RSU settlements give Cypherpunk (CYPH) director 168,750 common shares - Stock Titan
Cypherpunk Technologies (CYPH) director converts 168,750 RSUs into common shares - Stock Titan
Cypherpunk (CYPH) director converts 168,750 RSUs into common stock - Stock Titan
Director at Cypherpunk (CYPH) gains 168,750 shares via RSU settlements - Stock Titan
Director Loscalzo acquires 168,750 Cypherpunk (CYPH) shares via RSUs - Stock Titan
Director Cavanaugh acquires 168,750 Cypherpunk (CYPH) shares from RSUs - Stock Titan
CYPH.O PE Ratio & Valuation, Is CYPH.O Overvalued - Intellectia AI
CYPH.O Forecast — Price Prediction for 2026. Should I Buy CYPH.O? - Intellectia AI
CYPH Should I Buy - Intellectia AI
CYPH.O Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Cypherpunk Technologies Inc. (Formerly Leap Therapeutics) Combines Digital Privacy Tech and Cancer Drug Development – 2025 Annual Report Overview - Minichart
ZEC Rallies 20% After Cypherpunk Reports First Annual Profit - thedefiant.io
Security Notice: Cysic Foundation X Account Breached - Bitget
Cypherpunk reports full year 2025 financial results - marketscreener.com
Cypherpunk Technologies Reports Transformational 2025 Financial Results - Intellectia AI
Cypherpunk Technologies 10-K: Revenue $0, EPS $0.07 on $4.8M Net Income - TradingView
CYPH: 2025 saw a strategic pivot to Zcash, a return to profitability, and major digital asset gains - TradingView
Cypherpunk Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cypherpunk Technologies (CYPH) pivots to Zcash while advancing cancer drugs - Stock Titan
CYPH: Returned to profitability in 2025 with strong ZEC gains, new capital, and clinical progress - TradingView
[8-K] CYPHERPUNK TECHNOLOGIES INC. Reports Material Event | CYPH SEC FilingForm 8-K - Stock Titan
Cypherpunk Reports Full Year 2025 Financial Results - PR Newswire
CYPH.O Technical Analysis & Stock Price Forecast - Intellectia AI
Cypherpunk Technologies Inc. (CYPH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cypherpunk Technologies Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail
Cypherpunk Technologies Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns Cypherpunk (CYPH) after shares stay below $1 minimum bid - Stock Titan
Zcash Open Development Lab announced that it has received $25 million in funding from a group of investors - marketscreener.com
Cypherpunk Technologies: $5 Million Investment In Zcash Open Development Lab To Advance Privacy Infrastructure - Pulse 2.0
Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL) - Yellow.com
Cypherpunk Invests $5M in Zcash Company ZODL - Intellectia AI
Cypherpunk Makes $5M Investment into Zcash Open Development Lab - citybiz
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Leap Therapeutics, Inc. Common Stock (CYPH) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
CYPH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CYPH Technical Analysis & Stock Price Forecast - Intellectia AI
CYPH | Cypherpunk Technologies Inc. Common Institutional Ownership - Quiver Quantitative
Zcash Drops 60% as Treasury Buyer Hits Pause - Cointribune
Zcash Slides 60% as Treasury Buying Pauses and Cypherpunk’s Losses Mount - bitget.com
Is crypto still cypherpunk? With Miden co-founder Azeem Khan - Yahoo Finance
Zcash Down Over 50% Since Winklevoss-Backed DAT’s Last Purchase - thedefiant.io
Billionaire twins–backed stock surges 100% after buying $50M ‘encrypted Bitcoin’ - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Cypherpunk Technologies appoints Arjun Khemani as strategic advisor By Investing.com - Investing.com Nigeria
Cypherpunk Technologies Inc (CYPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):